Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CBRE Group | CBRE | Nov 19, 2024 | 132.16 | -0.38 |
CCC Intelligent Solutions | CCCS | Nov 19, 2024 | 11.78 | +1.46 |
CCSC Technology International A | CCTG | Nov 19, 2024 | 1.68 | +7.69 |
CDT Environmental Technology Investment Holdings | CDTG | Nov 19, 2024 | 3.10 | -0.32 |
CDW | CDW | Nov 19, 2024 | 174.05 | -2.26 |
CEA Industries | CEAD | Nov 19, 2024 | 6.56 | +0.67 |
CECO Environmental | CECO | Nov 19, 2024 | 29.69 | +4.62 |
Cedar Realty Trust B Pref | CDR-B | Nov 19, 2024 | 16.26 | -0.25 |
Cedar Realty Trust C Pref | CDR-C | Nov 19, 2024 | 14.10 | +1.81 |
CEF Income Composite Powershares | PCEF | Nov 19, 2024 | 19.34 | -0.10 |
Cel-Sci | CVM | Nov 19, 2024 | 0.65 | +14.32 |
Celanese | CE | Nov 19, 2024 | 72.20 | -1.10 |
Celcuity | CELC | Nov 19, 2024 | 12.47 | +0.08 |
Celestica | CLS | Nov 19, 2024 | 86.82 | +3.39 |
Celldex Therapeutics | CLDX | Nov 19, 2024 | 24.98 | +7.16 |
Cellebrite | CLBT | Nov 19, 2024 | 18.76 | +7.38 |
Cellectar Biosciences | CLRB | Nov 19, 2024 | 1.61 | -9.04 |
Cellectis ADR | CLLS | Nov 19, 2024 | 1.96 | +1.03 |
Celsius | CELH | Nov 19, 2024 | 27.29 | +5.82 |
Celularity A | CELU | Nov 19, 2024 | 2.92 | +5.42 |
Cementos Pacasmayo ADR | CPAC | Nov 19, 2024 | 6.30 | -0.79 |
CEMEX ADR | CX | Nov 19, 2024 | 5.44 | -0.73 |
Cemtrex | CETX | Nov 19, 2024 | 0.17 | -3.48 |
Cencora | COR | Nov 19, 2024 | 240.98 | -0.78 |
Cenntro | CENN | Nov 19, 2024 | 1.27 | -0.78 |
Cenovus Energy | CVE | Nov 19, 2024 | 16.05 | +0.44 |
Centene | CNC | Nov 19, 2024 | 57.81 | -1.73 |
CenterPoint Energy | CNP | Nov 19, 2024 | 31.40 | +0.80 |
Centerra Gold | CGAU | Nov 19, 2024 | 6.02 | +1.01 |
Centerspace | CSR-C | Nov 19, 2024 | 24.98 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.